MiMedx Group, Inc.

WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
CUSIP

602496101
SEDOL

B1Z3TW5
CIK

0001376339

www.mimedx.com
LEI:
FIGI: BBG000RJ6FL5
MDXG

MiMedx Group, Inc.
GICS: - · Sektor: Healthcare · Sub-Sektor: Biotechnology
NAME
MiMedx Group, Inc.
ISIN
US6024961012
TICKER
MDXG
MIC
XNAS
REUTERS
MDXG.OQ
BLOOMBERG
MDXG US
GIF DE 728x90
FÜR INVESTOREN
FÜR TRADER
Börsenhandel Warrants

Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von PR-Newswire bereitgestellt.

Mi., 11.09.2024       MiMedx Group
US6024961012

10 Former MiMedx Employees In Non-Compete Suit Fight Back Against MiMedx Schemes to "Bilk Medicare" and "Incentivize Fraud" in Counterclaims Filed by Mintz Attorneys

MARIETTA, Ga., Sept. 11, 2024 /PRNewswire/ -- 10 former employees of MiMedx Group, Inc. (NASDAQ: MDXG) have now filed counterclaims against the placental biologics company in response to a non-compete lawsuit filed by MiMedx earlier this year.  Among other allegations, the employee countersuits assert that in some cases that MiMedx engaged in "schemes to bilk Medicare and other government and third-party taxpayers" and that "MiMedx tried to compel its employees to continue selling a product that the U.S. Food and Drug Administration determined could not lawfully be marketed without prior FDA approval."  The filings describe the MiMedx suit as a "blatant intimidation tactic" against former employees who were "forced to leave" MiMedx as a result of its alleged wrongdoing.

Mi., 04.09.2024       MiMedx Group
US6024961012

Ex-MiMedx Employee Jake Heikkinen Files Counterclaims Alleging Schemes 'To Bilk Medicare' and 'Incentivize and Pressure Healthcare Providers' per Mintz Attorneys

MARIETTA, Ga., Sept. 4, 2024 /PRNewswire/ -- The third of 10 defendants who were sued earlier this year by MiMedx Group, Inc. (NASDAQ: MDXG) today filed counterclaims against the company. Jake Heikkinen, a former MiMedx employee, states in the filing that he left the placental biologics company because of "MiMedx's schemes to bilk Medicare and other government and third-party taxpayers" and "'to incentivize and pressure healthcare providers to treat wounded veterans, diabetics, chronic wound sufferers and other patients with medically unnecessary or unsuitable products—all to the detriment of patients and the federal government." Heikkinen also formally presented his answers and defenses to MiMedx's lawsuit which claimed that the 10 former employees, who all recently left the company, allegedly breached their contractual obligations to MiMedx. The filing describes the MiMedx suit as a "blatant intimidation tactic."

Mo., 26.08.2024       MiMedx Group
US6024961012

Ex-MiMedx Employee Caralyn Gargan Files Counterclaims for "Predatory Sales Practices" and "Incentivized Fraud" per Mintz Attorneys

MARIETTA, Ga., Aug. 26, 2024 /PRNewswire/ -- One of 10 defendants who were sued earlier this year by MiMedx Group, Inc. (NASDAQ: MDXG) today filed counterclaims against the placental biologics company.  Caralyn Gargan, a former MiMedx employee, filed the action against MiMedx for "predatory sales practices" and "incentivized fraud, including Medicare fraud." Gargan also formally presented her answers and defenses to MiMedx's lawsuit which claimed that the 10 former employees, who recently left the company, allegedly breached their contractual obligations to MiMedx. The filing describes the MiMedx suit as a "blatant intimidation tactic."

We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Informationen zu Product Placements